{
    "id": 7936,
    "name": "refractory T lymphoblastic leukemia/lymphoma",
    "source": "DOID",
    "definition": null,
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:7936",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02763384",
            "title": "BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 4275,
                    "therapyName": "BKT140 + Nelarabine",
                    "synonyms": null
                }
            ]
        }
    ]
}